Financials data is unavailable for this security.
View more
Year on year BioPharma Credit PLC 's revenues fell -5.59% from 110.01m to 103.86m. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from 89.14m to 84.96m, a -4.69% decrease.
| Gross margin | 87.57% |
|---|---|
| Net profit margin | 85.21% |
| Operating margin | 85.21% |
| Return on assets | 7.88% |
|---|---|
| Return on equity | 7.90% |
| Return on investment | 7.90% |
More ▼
Cash flow in USDView more
In 2021, cash reserves at BioPharma Credit PLC fell by 98.56m. However, the company earned 96.44m from its operations for a Cash Flow Margin of 92.85%. In addition the company used 94.82m on investing activities and also paid 100.16m in financing cash flows.
| Cash flow per share | -- |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 1.01 |
|---|---|
| Tangible book value per share | 1.01 |
More ▼
Balance sheet in USDView more
| Current ratio | 14.07 |
|---|---|
| Quick ratio | -- |
| Total debt/total equity | 0.00 |
|---|---|
| Total debt/total capital | 0.00 |
More ▼
Growth rates in USD
Year on year, growth in earnings per share excluding extraordinary items dropped -4.69%.
| Div yield(5 year avg) | 4.15% |
|---|---|
| Div growth rate (5 year) | -- |
| Payout ratio (TTM) | 47.83% |
| EPS growth(5 years) | -- |
|---|---|
| EPS (TTM) vs TTM 1 year ago | 17.04 |
More ▼
